SABS
Sab Biotherapeutics Inc.
NASDAQ · Healthcare
Annual Close Price
YEAR-END CLOSE · USD
| Year | Year-end Close | Annual Return |
|---|---|---|
| 2026 | $3.41 | -9.42% |
| 2025 | $3.77 | +3.01% |
| 2024 | $3.66 | -46.80% |
| 2023 | $6.88 | +16.61% |
| 2022 | $5.90 | -92.45% |
| 2021 | $78.10 | — |
| Year | Year-end Close | Annual Return |
|---|---|---|
| 2026 | $3.41 | -9.42% |
| 2025 | $3.77 | +3.01% |
| 2024 | $3.66 | -46.80% |
| 2023 | $6.88 | +16.61% |
| 2022 | $5.90 | -92.45% |
| 2021 | $78.10 | — |